Naka, Nobuyuki <br/><br/>
Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Sep 2002 
 - 319-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/s0169-5002(02)00073-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Camptothecin--administration & dosage<br/>Carboplatin--administration & dosage<br/>Carcinoma, Small Cell--drug therapy<br/>Disease Progression<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Irinotecan<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Survival<br/>Thrombocytopenia--chemically induced